Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion

Journal of Nutritional Biochemistry

Volumn 33, Issue , 2016, Pages 91-102

  Kitson, Alex P ^a   Metherel, Adam H ^a   Chen, Chuck T ^a,d   Domenichiello, Anthony F ^a   Trépanier, Marc Olivier ^a   Berger, Alvin ^b,c   Bazinet, Richard P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Arctic Nutrition AS   (Norway)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Brain; Docosahexaenoic acid; Phospholipid; Serum; Triacylglycerol; Uptake

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; PHOSPHOLIPID; TRIACYLGLYCEROL; ESSENTIAL FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLCHOLINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN; BRAIN REGION; CEREBELLUM; HEART; HIPPOCAMPUS; LIPID BLOOD LEVEL; NONHUMAN; RADIOACTIVITY; RAT; SERUM; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; BRAIN STEM; COMPARATIVE STUDY; DEFICIENCY; DIET THERAPY; DIETARY SUPPLEMENT; LONG EVANS RAT; MALE; METABOLISM; NERVE CELL; NUTRITIONAL DEFICIENCY; RANDOMIZATION;

ANIMALS; BRAIN; BRAIN STEM; DEFICIENCY DISEASES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; MALE; NEURONS; ORGAN SPECIFICITY; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; RANDOM ALLOCATION; RATS, LONG-EVANS; TRIGLYCERIDES; TRITIUM;

EID: 84964553500     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.02.009     Document Type: Article

References (95)

1. Igarashi M., Ma K., Gao F., Kim H.W., Greenstein D., Rapoport S.I., et al. Brain lipid concentrations in bipolar disorder. J Psychiatr Res 2010, 44:177-182.
2. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C., Arnold J.T., Rapoport S.I., et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007, 12:36-46.
3. Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., et al. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 2009, 111:510-521.
4. Su H.M. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem 2010, 21:364-373.
5. Orr S.K., Palumbo S., Bosetti F., Mount H.T., Kang J.X., Greenwood C.E., et al. Unesterified docosahexaenoic acid is protective in neuroinflammation. J Neurochem 2013, 127:378-393.
6. Brenna J.T. Animal studies of the functional consequences of suboptimal polyunsaturated fatty acid status during pregnancy, lactation and early post-natal life. Matern Child Nutr 2011, 7(Suppl. 2):59-79.
7. Igarashi M., Ma K., Gao F., Kim H.W., Rapoport S.I., Rao J.S. Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. J Alzheimers Dis 2011, 24:507-517.
8. Soderberg M., Edlund C., Kristensson K., Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991, 26:421-425.
9. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005, 115:2774-2783.
10. Astarita G., Jung K.M., Berchtold N.C., Nguyen V.Q., Gillen D.L., Head E., et al. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One 2010, 5.
11. Cunnane S.C., Schneider J.A., Tangney C., Tremblay-Mercier J., Fortier M., Bennett D.A., et al. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2012, 29:691-697.
12. Cunnane S.C., Chouinard-Watkins R., Castellano C.A., Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: can we reconcile the evidence?. Prostaglandins Leukot Essent Fatty Acids 2013, 88:61-70.
13. McNamara R.K., Jandacek R., Tso P., Dwivedi Y., Ren X., Pandey G.N. Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease. J Psychiatr Res 2013, 47:1187-1191.
14. McNamara R.K., Hahn C.G., Jandacek R., Rider T., Tso P., Stanford K.E., et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007, 62:17-24.
15. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K.E., Hahn C.G., et al. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res 2008, 160:285-299.
16. McNamara R.K., Jandacek R., Rider T., Tso P., Hahn C.G., Richtand N.M., et al. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophr Res 2007, 91:37-50.
17. Hamazaki K., Hamazaki T., Inadera H. Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2013, 210:346-350.
18. Hamazaki K., Hamazaki T., Inadera H. Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder. J Psychiatr Res 2012, 46:1024-1028.
19. Fraser T., Tayler H., Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res 2010, 35:503-513.
20. Oster T., Pillot T. Docosahexaenoic acid and synaptic protection in Alzheimer's disease mice. Biochim Biophys Acta 2010, 1801:791-798.
21. Cole G.M., Frautschy S.A. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health 2006, 18:249-259.
22. Zugno A.I., Chipindo H.L., Volpato A.M., Budni J., Steckert A.V., de Oliveira M.B., et al. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia. Neuroscience 2014, 259:223-231.
23. Park Y., Moon H.J., Kim S.H. N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J Nutr Biochem 2012, 23:924-928.
24. Igarashi M., DeMar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res 2007, 48:1150-1158.
25. Moore S.A., Yoder E., Murphy S., Dutton G.R., Spector A.A. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem 1991, 56:518-524.
26. Contreras M.A., Greiner R.S., Chang M.C., Myers C.S., Salem N., Rapoport S.I. Nutritional deprivation of alpha-linolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J Neurochem 2000, 75:2392-2400.
27. Purdon D., Arai T., Rapoport S. No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J Lipid Res 1997, 38:526-530.
28. Chen C.T., Kitson A.P., Hopperton K.E., Domenichiello A.F., Lin L., Trepanier M.O., et al. Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. Sci Rep 2015, [in press].
29. Nguyen L.N., Ma D., Shui G., Wong P., Cazenave-Gassiot A., Zhang X., et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014, 509.
30. Thies F., Pillon C., Moliere P., Lagarde M., Lecerf J. Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol 1994, 267:R1273-R1279.
31. Ramprasath V.R., Eyal I., Zchut S., Jones P.J. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis 2013, 12:178.
32. Ulven S.M., Kirkhus B., Lamglait A., Basu S., Elind E., Haider T., et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46:37-46.
33. Maki K.C., Reeves M.S., Farmer M., Griinari M., Berge K., Vik H., et al. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res 2009, 29:609-615.
34. Schuchardt J.P., Schneider I., Meyer H., Neubronner J., von Schacky C., Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis 2011, 10:145.
35. Vaisman N., Kaysar N., Zaruk-Adasha Y., Pelled D., Brichon G., Zwingelstein G., et al. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr 2008, 87:1170-1180.
36. Carnielli V.P., Verlato G., Pederzini F., Luijendijk I., Boerlage A., Pedrotti D., et al. Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Am J Clin Nutr 1998, 67:97-103.
37. Yurko-Mauro K., Kralovec J., Bailey-Hall E., Smeberg V., Stark J.G., Salem N. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Lipids Health Dis 2015, 14:99.
38. Salem N., Kuratko C.N. A reexamination of krill oil bioavailability studies. Lipids Health Dis 2014, 13:137.
39. Ghasemifard S., Turchini G.M., Sinclair A.J. Omega-3 long chain fatty acid "bioavailability": a review of evidence and methodological considerations. Prog Lipid Res 2014, 56:92-108.
40. Nichols P.D., Kitessa S.M., Abeywardena M. Commentary on a trial comparing krill oil versus fish oil. Lipids Health Dis 2014, 13:2.
41. Ramprasath V.R., Eyal I., Zchut S., Jones P.J. Response to commentary on a trial comparing krill oil versus fish oil. Lipids Health Dis 2014, 13:17.
42. Liu L., Bartke N., Van Daele H., Lawrence P., Qin X., Park H.G., et al. Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets. J Lipid Res 2014, 55:531-539.
43. Graf B.A., Duchateau G.S., Patterson A.B., Mitchell E.S., van Bruggen P., Koek J.H., et al. Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Prostaglandins Leukot Essent Fatty Acids 2010, 83:89-96.
44. Zierenberg O., Grundy S.M. Intestinal absorption of polyenephosphatidylcholine in man. J Lipid Res 1982, 23:1136-1142.
45. Amate L., Gil A., Ramirez M. Feeding infant piglets formula with long-chain polyunsaturated fatty acids as triacylglycerols or phospholipids influences the distribution of these fatty acids in plasma lipoprotein fractions. J Nutr 2001, 131:1250-1255.
46. DeMar J.C., Ma K., Bell J.M., Rapoport S.I. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem 2004, 91:1125-1137.
47. Folch J., Lees M., Sloane Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
48. Domenichiello A.F., Chen C.T., Trepanier M.O., Stavro P.M., Bazinet R.P. Whole body synthesis rates of docosahexaenoic acid (DHA) from alpha-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats. J Lipid Res 2013, 55:62-74.
49. Chen C.T., Domenichiello A.F., Trepanier M.O., Liu Z., Masoodi M., Bazinet R.P. The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. J Lipid Res 2013, 54:2410-2422.
50. Robinson P.J., Noronha J., DeGeorge J.J., Freed L.M., Nariai T., Rapoport S.I. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev 1992, 17:187-214.
51. Lin L.E., Chen C.T., Hildebrand K.D., Liu Z., Hopperton K.E., Bazinet R.P. Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids. J Lipid Res 2015, 56:390-402.
52. Orr S.K., Tong J.Y., Kang J.X., Ma D.W., Bazinet R.P. The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. Neurochem Res 2010, 35:811-819.
53. Wang W.Q., Gustafson A. One-dimensional thin-layer chromatographic separation of phospholipids and lysophospholipids from tissue lipid extracts. J Chromatogr 1992, 581:139-142.
54. Morrison W.R., Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964, 4:600-608.
55. Chen C.T., Liu Z., Bazinet R.P. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J Neurochem 2011, 116:363-373.
56. Yang J., Chen Z.Y., Cunnane S.C. Application of the balance method to determining accumulation, metabolism, and apparent oxidation of linoleic and alpha-linolenic acids in the pregnant rat. Metabolism 1994, 43:940-944.
57. Cunnane S.C., Anderson M.J. The majority of dietary linoleate in growing rats is beta-oxidized or stored in visceral fat. J Nutr 1997, 127:146-152.
58. Poumes-Ballihaut C., Langelier B., Houlier F., Alessandri J.M., Durand G., Latge C., et al. Comparative bioavailability of dietary alpha-linolenic and docosahexaenoic acids in the growing rat. Lipids 2001, 36:793-800.
59. Belayev L., Khoutorova L., Atkins K.D., Eady T.N., Hong S., Lu Y., et al. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl Stroke Res 2011, 2:33-41.
60. Hachem M., Geloen A., Van A.L., Foumaux B., Fenart L., Gosselet F., et al. Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid. Mol Neurobiol 2015, 10.1007/s12035-015-9228-9.
61. Lagarde M., Bernoud N., Brossard N., Lemaitre-Delaunay D., Thies F., Croset M., et al. Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J Mol Neurosci 2001, 16:201-204. [discussion 15-21].
62. Barrett E.C., McBurney M.I., Ciappio E.D. Omega-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv Nutr 2014, 5:268-277.
63. Di Marzo V., Grinari M., Carta G., Murru E., Ligresti A., Cordeddu L., et al. Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 2010, 20:231-235.
64. Goti D., Hrzenjak A., Levak-Frank S., Frank S., van der Westhuyzen D.R., Malle E., et al. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem 2001, 76:498-508.
65. Vitali C., Wellington C.L., Calabresi L. HDL and cholesterol handling in the brain. Cardiovasc Res 2014, 103:405-413.
66. Panzenboeck U., Balazs Z., Sovic A., Hrzenjak A., Levak-Frank S., Wintersperger A., et al. ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J Biol Chem 2002, 277:42781-42789.
67. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271:518-520.
68. Polozova A., Salem N. Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: a comparative study of 14C-DHA and 3H-oleic acid tracers. J Mol Neurosci 2007, 33:56-66.
69. Polozova A., Gionfriddo E., Salem N. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins Leukot Essent Fatty Acids 2006, 75:183-190.
70. Rahman T., Taha A.Y., Song B.J., Orr S.K., Liu Z., Chen C.T., et al. The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations. Prostaglandins Leukot Essent Fatty Acids 2010, 82:141-145.
71. Chen C.T., Ma D.W., Kim J.H., Mount H.T., Bazinet R.P. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J Lipid Res 2008, 49:147-152.
72. Tso P., Hayashi H. The physiology and regulation of the intestinal absorption and transport of omega-3 and omega-6 fatty acids. Adv Prostaglandin Thromboxane Leukot Res 1989, 19:623-626.
73. Schuchardt J.P., Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013, 89:1-8.
74. Arima N., Inoue A., Makide K., Nonaka T., Aoki J. Surface loops of extracellular phospholipase A(1) determine both substrate specificity and preference for lysophospholipids. J Lipid Res 2012, 53:513-521.
75. Aloulou A., Frikha F., Noiriel A., Bou Ali M., Abousalham A. Kinetic and structural characterization of triacylglycerol lipases possessing phospholipase A1 activity. Biochim Biophys Acta 1841, 2014:581-587.
76. Ono T., Tojo H., Inoue K., Kagamiyama H., Yamano T., Okamoto M. Rat pancreatic phospholipase A2: purification, characterization, and N-terminal amino acid sequence. J Biochem (Tokyo) 1984, 96:785-792.
77. Roussel A., Yang Y., Ferrato F., Verger R., Cambillau C., Lowe M. Structure and activity of rat pancreatic lipase-related. protein 2. J Biol Chem 1998, 273:32121-32128.
78. Le Kim D., Betzing H. Intestinal absorption of polyunsaturated phosphatidylcholine in the rat. Hoppe Seylers Z Physiol Chem 1976, 357:1321-1331.
79. Tso P., Kendrick H., Balint J.A., Simmonds W.J. Role of biliary phosphatidylcholine in the absorption and transport of dietary triolein in the rat. Gastroenterology 1981, 80:60-65.
80. Mansbach C.M., Arnold A., Cox M.A. Factors influencing triacylglycerol delivery into mesenteric lymph. Am J Physiol 1985, 249:G642-G648.
81. Nishimukai M., Wakisaka T., Hara H. Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats. Lipids 2003, 38:1227-1235.
82. Kohler A., Sarkkinen E., Tapola N., Niskanen T., Bruheim I. Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects-a randomized, single-dose, cross-over trial. Lipids Health Dis 2015, 14:19.
83. Batetta B., Griinari M., Carta G., Murru E., Ligresti A., Cordeddu L., et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese zucker rats. J Nutr 2009, 139:1495-1501.
84. Berger A., Gershwin M.E., German J.B. Effects of various dietary fats on cardiolipin acyl composition during ontogeny of mice. Lipids 1992, 27:605-612.
85. Malis C.D., Weber P.C., Leaf A., Bonventre J.V. Incorporation of marine lipids into mitochondrial membranes increases susceptibility to damage by calcium and reactive oxygen species: evidence for enhanced activation of phospholipase A2 in mitochondria enriched with n-3 fatty acids. Proc Natl Acad Sci U S A 1990, 87:8845-8849.
86. Plourde M., Chouinard-Watkins R., Rioux-Perreault C., Fortier M., Dang M.T., Allard M.J., et al. Kinetics of 13C-DHA before and during fish-oil supplementation in healthy older individuals. Am J Clin Nutr 2014, 100:105-112.
87. Ghasemifard S., Hermon K., Turchini G.M., Sinclair A.J. Metabolic fate (absorption, beta-oxidation and deposition) of long-chain n-3 fatty acids is affected by sex and by the oil source (krill oil or fish oil) in the rat. Br J Nutr 2015, 1-9.
88. Chen C.T., Kitson A.P., Hopperton K.E., Domenichiello A.F., Trepanier M.O., Lin L.E., et al. Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. Sci Rep 2015, 5:15791.
89. Sinclair A.J. Incorporation of radioactive polyunsaturated fatty acids into liver and brain of developing rat. Lipids 1975, 10:175-184.
90. Sheaff Greiner R.C., Zhang Q., Goodman K.J., Giussani D.A., Nathanielsz P.W., Brenna J.T. Linoleate, alpha-linolenate, and docosahexaenoate recycling into saturated and monounsaturated fatty acids is a major pathway in pregnant or lactating adults and fetal or infant rhesus monkeys. J Lipid Res 1996, 37:2675-2686.
91. Rhee S.K., Kayani A.J., Ciszek A., Brenna J.T. Desaturation and interconversion of dietary stearic and palmitic acids in human plasma and lipoproteins. Am J Clin Nutr 1997, 65:451-458.
92. Emken E.A., Rohwedder W.K., Adlof R.O., Rakoff H., Gulley R.M. Metabolism in humans of cis-12,trans-15-octadecadienoic acid relative to palmitic, stearic, oleic and linoleic acids. Lipids 1987, 22:495-504.
93. Wijendran V., Huang M.C., Diau G.Y., Boehm G., Nathanielsz P.W., Brenna J.T. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res 2002, 51:265-272.
94. Igarashi M., DeMar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J Lipid Res 2007, 48:152-164.
95. Chowdhury R., Warnakula S., Kunutsor S., Crowe F., Ward H.A., Johnson L., et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014, 160:398-406.